303 related articles for article (PubMed ID: 12499612)
1. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT).
Mabuchi H; Kita T; Matsuzaki M; Matsuzawa Y; Nakaya N; Oikawa S; Saito Y; Sasaki J; Shimamoto K; Itakura H;
Circ J; 2002 Dec; 66(12):1096-100. PubMed ID: 12499612
[TBL] [Abstract][Full Text] [Related]
2. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.
Matsuzaki M; Kita T; Mabuchi H; Matsuzawa Y; Nakaya N; Oikawa S; Saito Y; Sasaki J; Shimamoto K; Itakura H;
Circ J; 2002 Dec; 66(12):1087-95. PubMed ID: 12499611
[TBL] [Abstract][Full Text] [Related]
3. Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients.
Matsuzawa Y; Kita T; Mabuchi H; Matsuzaki M; Nakaya N; Oikawa S; Saito Y; Sasaki J; Shimamoto K; Itakura H;
Circ J; 2003 Apr; 67(4):287-94. PubMed ID: 12655157
[TBL] [Abstract][Full Text] [Related]
4. Relationship between coronary events and serum cholesterol during 10 years of low-dose simvastatin therapy: long-term efficacy and safety in Japanese patients with hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study, a prospective large-scale observational cohort study.
Itakura H; Kita T; Mabuchi H; Matsuzaki M; Matsuzawa Y; Nakaya N; Oikawa S; Saito Y; Sasaki J; Shimamoto K;
Circ J; 2008 Aug; 72(8):1218-24. PubMed ID: 18654003
[TBL] [Abstract][Full Text] [Related]
5. Large-scale cohort study on the relationship between serum lipid concentrations and risk of cerebrovascular disease under low-dose simvastatin in Japanese patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT).
Nakaya N; Kita T; Mabuchi H; Matsuzaki M; Matsuzawa Y; Oikawa S; Saito Y; Sasaki J; Shimamoto K; Itakura H;
Circ J; 2005 Sep; 69(9):1016-21. PubMed ID: 16127179
[TBL] [Abstract][Full Text] [Related]
6. Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on low-dose simvastatin therapy: implication from Japan Lipid Intervention Trial (J-LIT).
Oikawa S; Kita T; Mabuchi H; Matsuzaki M; Matsuzawa Y; Nakaya N; Saito Y; Sasaki J; Shimamoto K; Itakura H;
Atherosclerosis; 2007 Apr; 191(2):440-6. PubMed ID: 16765358
[TBL] [Abstract][Full Text] [Related]
7. Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial.
Horiuchi H; Kita T; Mabuchi H; Matsuzaki M; Matsuzawa Y; Nakaya N; Oikawa S; Saito Y; Sasaki J; Shimamoto K; Itakura H;
J Am Geriatr Soc; 2004 Dec; 52(12):1981-7. PubMed ID: 15571531
[TBL] [Abstract][Full Text] [Related]
8. [Results of clinical epidemiology and intervention trial of hyperlipidemia in Japan].
Itakura H
Nihon Rinsho; 2002 May; 60(5):889-98. PubMed ID: 12029990
[TBL] [Abstract][Full Text] [Related]
9. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
10. Effects of low-dose simvastatin therapy on serum lipid levels in patients with moderate hypercholesterolemia: a 12-month study. The Simvastatin Study Group.
Itoh T; Matsumoto M; Hougaku H; Handa N; Tsubakihara Y; Yamada Y; Imaizumi M; Hoshi M; Shimazu Y; Hori M; Kawamori R; Ueda N; Fusamoto H; Kamada T
Clin Ther; 1997; 19(3):487-97. PubMed ID: 9220213
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients.
Averna M; Zaninelli A; Le Grazie C; Gensini GF
J Clin Lipidol; 2010; 4(4):272-8. PubMed ID: 21122660
[TBL] [Abstract][Full Text] [Related]
12. Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia.
Li JJ; Chen MZ; Chen X; Fang CH
Clin Cardiol; 2003 Oct; 26(10):472-6. PubMed ID: 14579918
[TBL] [Abstract][Full Text] [Related]
13. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
[TBL] [Abstract][Full Text] [Related]
14. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study).
Garmendia F; Brown AS; Reiber I; Adams PC
Curr Med Res Opin; 2000; 16(3):208-19. PubMed ID: 11191012
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
Foody JM; Brown WV; Zieve F; Adewale AJ; Flaim D; Lowe RS; Jones-Burton C; Tershakovec AM
Am J Cardiol; 2010 Nov; 106(9):1255-63. PubMed ID: 21029821
[TBL] [Abstract][Full Text] [Related]
16. [Lipid intervention and coronary heart disease in men less than 56 years of age. The Coronary Intervention Study: CIS].
Rensing UF; Bestehorn HP; Roskamm H; Petersen J; Betz P; Spinder M; Benesch L; Schemeitat K; Blümchen G; Claus J; Wieland H; Böcker JF; Neiss A; Stiepel E; Mathes P; Kappenberger L; Braunagel K; Peters K; Meister G; Samek L; Schuon J; Leimenstoll B; Kiefer H
Z Kardiol; 1999 Apr; 88(4):270-82. PubMed ID: 10408031
[TBL] [Abstract][Full Text] [Related]
17. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
Ballantyne CM; Abate N; Yuan Z; King TR; Palmisano J
Am Heart J; 2005 Mar; 149(3):464-73. PubMed ID: 15864235
[TBL] [Abstract][Full Text] [Related]
18. The risk of cardiovascular events in Japanese hypertensive patients with hypercholesterolemia: sub-analysis of the Japan Lipid Intervention Trial (J-LIT) Study, a large-scale observational cohort study.
Shimamoto K; Kita T; Mabuchi H; Matsuzaki M; Matsuzawa Y; Nakaya N; Oikawa S; Saito Y; Sasaki J; Itakura H;
Hypertens Res; 2005 Nov; 28(11):879-87. PubMed ID: 16555576
[TBL] [Abstract][Full Text] [Related]
19. Gender difference in coronary events in relation to risk factors in Japanese hypercholesterolemic patients treated with low-dose simvastatin.
Sasaki J; Kita T; Mabuchi H; Matsuzaki M; Matsuzawa Y; Nakaya N; Oikawa S; Saito Y; Shimamoto K; Kono S; Itakura H;
Circ J; 2006 Jul; 70(7):810-4. PubMed ID: 16799230
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
Plans-Rubió P
Am J Cardiovasc Drugs; 2006; 6(3):177-88. PubMed ID: 16780391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]